Why Might AI Prevail?



 
We live in a technological and data driven world in this new age where AI is poised to have a prominent effect in the future of medicine and healthcare. Several factors have come together in the past few years to support the quickening of AI developments of medicine which include the amount of healthcare data collected in recent years, low cost of high level computing which can process large datasets, the increasing prevalence of EMR and overall advances in computing technologies which have all fueled AI in drug development . With such advancements, the cost of implementing AI have reduced significantly because of which it would be easy for more healthcare facilities to use AI so we can say that AI in healthcare and drug development is here to stay
.

Comments

Post a Comment

Popular posts from this blog

A Machine Learning in Healthcare SWOT Analysis

Image
  Photo by National Cancer Institute on Unsplash Machine Learning is making sweeping improvements to many industries, healthcare being one of them.  The impact ML can have on a sector or industry is as unique as the industry itself. Pharmacology is able to refine products by miniscule amounts to ensure quality and safety. The layer of coating that covers pill tablets is being reevaluated for accuracy by ML's capacity to find novel patterns in vast amounts of data. Resource management in hospitals is able to track inventory in real-time, giving physicians updates on what supplies are available. This is also helping in streamline the patient intake process. Radiologists are using AI to help identify chronic pulmonary hypertension faster using ML to find new pattern indicators. Personalized medicine, or precision medicine, is using ML to create treatment plans specific to a patient with increasing accuracy using predictive analysis.  So where does this leave business managers? The tim
Read more

Machine Learning in Pharmaceutical Research and Development

Image
Lets look at the Pharmaceutical Industry for a minute...  Its a complex and competitive world out there for a multitude of reasons: There are time limits on patented treatments, customers have more bargaining power, and we are moving on to tackle more complex diseases. The more complex the disease, the more complex the research and development (R&D) phase for treatments. The R&D pipeline for treatments of rare, chronic, degenerative diseases is lengthy and costly, with many false starts and do-overs involved. How does it work? A simplified version is that researchers test the interaction of different molecules to gauge is a combination would be effective in killing the molecules of the disease in question. The process is traditionally done by human researchers using vast amounts of data about the properties of molecules to see the interaction between multiple molecules, and then their interaction with the disease.  As you can guess, its an extremely time consuming and costly pr
Read more

Global Trends in Pharmaceutical Drug Development

Image
Health care is the center of our world right now. But it has been the center of many people's world for decades. If you work in the Pharmaceutical industry you know how much money, resources, and time is constantly being utilized by the field. Resources are still stretched thin across the Research and Development sector, the sector responsible for finding new drugs to fight diseases.  The drug R&D pipeline is costing companies and investors more and more financially, but it is paying off.  There has also been a steady increase in drugs discovered and being investigated. Lets take a look at the Global Trends in Big Pharma...   Curious to know more?  We got the data needed to make these charts from Evaluate and PharmaExec !  Follow the links below.. EvaluatePharma- World Preview 2020, Outlook to 2026 Pharm Exec's Top 50 Companies 2020 Published by Michael Christel July 8, 2020
Read more